Kures

0 followers


Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder.The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. I... Read more


Org chart

Chad Beyer
Ph.d., CEO
Collapse
Glenn Short
Translational Lead
Cara Baugh
Member Board Of Directors

Teams

This company has no teams yet